tm logo

Monitor this mark

View On USPTO

NGENLA
Live/Registered
REGISTERED

on 05 Mar 2019

Last Applicant/ Owned by

Pfizer Inc.

66 Hudson Boulevard East

New York

NY

10001-2192

Serial Number

86730692 filed on 20th Aug 2015

Registration Number

5692027 registered on 05th Mar 2019

in the Principal Register

Correspondent Address

Janina Gorbach

Janina Gorbach Pfizer Inc.

New York, NY 10001-2192

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NGENLA

Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones

First Use Date in General

14th Jan 2019

First Use Date in Commerce

14th Jan 2019

Mark Details

Serial Number

No 86730692

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T 407889

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
04th Dec 2024TEAS SECTION 8 & 15 RECEIVED
05th Mar 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27th Mar 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27th Mar 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
27th Mar 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27th Mar 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27th Mar 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
27th May 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
26th Mar 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26th Mar 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED